The lack of association between treatment with hGH and tumor recurrence, secondary neoplasia and/or increased mortality from cancer was reported by other investigators in other centers, including a recent meta-analysis published by the Endocrine Society (4, 25). The gene discussed is GH1; the disease is cancer.